Badar A, Jamil MT, Azam F et al (2020) Comparison of oral rifampicin with observation alone in treatment of acute central serous chorioretinopathy. Int J Retina 3(1):Published online February 2020. https://doi.org/10.35479/ijretina.2020.vol003.iss001.103. Accessed November 27, 2024. Available at: https://www.ijretina.com/index.php/ijretina/article/view/103
Bousquet E, Zhao M, Daruich A, Behar-Cohen F (2019) Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: review of the pre-clinical and clinical evidence. Exp Eye Res 187:107754. https://doi.org/10.1016/j.exer.2019.107754
Article CAS PubMed Google Scholar
Liew G, Quin G, Gillies M, Fraser-Bell S (2013) Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol 41(2):201–214. https://doi.org/10.1111/j.1442-9071.2012.02848.x
Daruich A, Matet A, Marchionno L et al (2017) Acute central serious chorioretinopathy: factors influencing episode duration. Retina 37(10):1905–1915. https://doi.org/10.1097/IAE.0000000000001443
Article PubMed PubMed Central Google Scholar
Iida T, Yannuzzi LA, Spaide RF, Borodoker N, Carvalho CA, Negrao S (2003) Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina 23(1):1–138. https://doi.org/10.1097/00006982-200302000-00001
Piccolino FC, De La Longrais RR, Manea M, Cicinelli S, Ravera G (2008) Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy. Retina 28(8):1146–1150. https://doi.org/10.1097/IAE.0b013e318175421f
Mohabati D, van Dijk EH, van Rijssen TJ et al (2018) Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy. Clin Ophthalmol 12:2167–2176 Published 2018 Oct 24. https://doi.org/10.2147/OPTH.S174573
Article CAS PubMed PubMed Central Google Scholar
Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology 115(1):169–173. https://doi.org/10.1016/j.ophtha.2007.02.032
Ross A, Ross AH, Mohamed Q (2011) Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol 22(3):166–173. https://doi.org/10.1097/ICU.0b013e3283459826
Spaide RF, Campeas L, Haas A et al (1996) Central serous chorioretinopathy in younger and older adults. Ophthalmology 103(12):2070–2080. https://doi.org/10.1016/s0161-6420(96)30386-2
Article CAS PubMed Google Scholar
Dolz-Marco R, Dansingani K, Freund KB (2016) The pachychoroid clinical spectrum: a new risk and disease modifier in macular disorders. Retina Today. Available at: https://retinatoday.com/articles/2016-may-june/the-pachychoroid-clinical-spectrum. Acessed November 06, 2024
Pichi F, Aggarwal K, Neri P et al (2018) Choroidal biomarkers. Indian J Ophthalmol 66(12):1716–1726. https://doi.org/10.4103/ijo.IJO_893_18
Article PubMed PubMed Central Google Scholar
Nkrumah G, Paez-Escamilla M, Singh SR et al (2020) Biomarkers for central serous chorioretinopathy. Ther Adv Ophthalmol 12:2515841420950846 Published 2020 Aug 24. https://doi.org/10.1177/2515841420950846
Article PubMed PubMed Central Google Scholar
Agrawal R, Gupta P, Tan KA, Cheung CM, Wong TY, Cheng CY (2016) Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study. Sci Rep 6:21090 Published 2016 Feb 12. https://doi.org/10.1038/srep21090
Article CAS PubMed PubMed Central Google Scholar
Lim G, Kim KT, Seo EJ (2023) Relationships between choroidal characteristics and disease activity in acute central serous chorioretinopathy. J Korean Ophthalmol Soc 64(8):709–717 Published online August 15. https://doi.org/10.3341/jkos.2023.64.8.709
Daruich A, Matet A, Dirani A et al (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82–118. https://doi.org/10.1016/j.preteyeres.2015.05.003
Article CAS PubMed Google Scholar
Agrawal R, Chhablani J, Tan KA, Shah S, Sarvaiya C, Banker A (2016) Choroidal vascularity index in central serous chorioretinopathy. Retina 36(9):1646–1651. https://doi.org/10.1097/IAE.0000000000001040
Rasheed MA, Goud A, Mohamed A, Vupparaboina KK, Chhablani J (2018) Change in choroidal vascularity in acute central serous chorioretinopathy. Indian J Ophthalmol 66(4):530–534. https://doi.org/10.4103/ijo.IJO_1160_17
Article PubMed PubMed Central Google Scholar
May CA, Rutkowski P (2019) The horizontal raphe of the Human Retina and its Watershed zones. Vis (Basel) 3(4):60. https://doi.org/10.3390/vision3040060
Spaide RF, Cheung CMG, Matsumoto H et al (2022) Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders. Prog Retin Eye Res 86:100973. https://doi.org/10.1016/j.preteyeres.2021.100973
Article CAS PubMed Google Scholar
Tan CS, Ouyang Y, Ruiz H, Sadda SR (2012) Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 53(1):261–266. https://doi.org/10.1167/iovs.11-8782
Pauleikhoff LJB, Diederen RMH, Chang-Wolf JM et al (2024) Choroidal vascular changes on Ultrawidefield Indocyanine Green Angiography in Central Serous Chorioretinopathy: Certain study report 1. Ophthalmol Retina 8(3):254–263. https://doi.org/10.1016/j.oret.2023.10.007
Zarnegar A, Ong J, Matsyaraja T, Arora S, Chhablani J (2023) Pathomechanisms in central serous chorioretinopathy: a recent update. Int J Retina Vitreous 9(1):3. https://doi.org/10.1186/s40942-023-00443-2
Matsumoto H, Hoshino J, Nakamura K, Kishi S, Akiyama H (2023) Attenuation of irradiated choroid and its regional vortex veins in central serous chorioretinopathy after photodynamic therapy. Sci Rep 13(1):19903. https://doi.org/10.1038/s41598-023-47325-z
Spaide RF, Ledesma-Gil G, Gemmy Cheung CM (2021) Intervortex venous anastomosis in pachychoroid-related disorders. Retina 41(5):997–1004. https://doi.org/10.1097/IAE.0000000000003004
Article CAS PubMed Google Scholar
Matsumoto H, Hoshino J, Mukai R et al (2020) Vortex Vein Anastomosis at the Watershed in Pachychoroid Spectrum diseases. Ophthalmol Retina 4(9):938–945. https://doi.org/10.1016/j.oret.2020.03.024
Fernández-Vigo JI, Rego-Lorca D, Moreno-Morillo FJ et al (2023) Intervortex venous anastomosis in the Macula in Central Serous Chorioretinopathy imaged by En Face Optical Coherence Tomography. J Clin Med 12(6):2088. https://doi.org/10.3390/jcm12062088
Article PubMed PubMed Central Google Scholar
Ramtohul P, Cabral D, Oh D, Galhoz D, Freund KB (2023) En face Ultrawidefield OCT of the Vortex Vein System in Central Serous Chorioretinopathy. Ophthalmol Retina 7(4):346–353. https://doi.org/10.1016/j.oret.2022.10.001
Rana V, Gupta V, Spaide RF et al (2023) Venous overload choroidopathy associated with idiopathic intracranial hypertension. Retin Cases Brief Rep 17(4):448–454. https://doi.org/10.1097/ICB.0000000000001216
Marin AI, Petrash CC, Jolly A, Gange WS, Mathias MT (2023) A case of venous overload choroidopathy in the setting of superior vena cava syndrome. Am J Ophthalmol Case Rep 32:101918. https://doi.org/10.1016/j.ajoc.2023.101918
Article PubMed PubMed Central Google Scholar
Kishi S, Matsumoto H (2022) A new insight into pachychoroid diseases: remodeling of choroidal vasculature. Graefes Arch Clin Exp Ophthalmol 260(11):3405–3417. https://doi.org/10.1007/s00417-022-05687-6
Article PubMed PubMed Central Google Scholar
Cheung CMG, Dansingani KK, Koizumi H et al (2024) Pachychoroid disease: review and update. Eye (Lond). https://doi.org/10.1038/s41433-024-03253-4.
Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB (2019) Pachychoroid disease. Eye (Lond) 33(1):14–33.
留言 (0)